Literature DB >> 30907619

Upregulation of hippocampal extracellular signal-regulated kinase (ERK)-2 induces antidepressant-like behavior in the rat forced swim test.

Sergio D Iñiguez1, Lyonna F Parise2, Mary Kay Lobo3, Francisco J Flores-Ramirez1, Israel Garcia-Carachure1, Brandon L Warren4, Alfred J Robison5.   

Abstract

The hippocampus mediates responses to affect-related behavior in preclinical models of pharmacological antidepressant efficacy, such as the forced swim test. However, the molecular mechanisms that regulate escape-directed behavior in this preclinical model of despair are not well understood. Here, using viral-mediated gene transfer, we assessed how overexpression of extracellular signal-regulated protein kinase (ERK)-2 within the dorsal hippocampus influenced behavioral reactivity to inescapable swimming stress in adult male Sprague-Dawley rats. When compared to controls, rats overexpressing hippocampal ERK-2 displayed increases in the time to initially adopt a posture of immobility, along with decreases in total time spent immobile, without influencing general locomotor activity. Collectively, the results indicate that hippocampal upregulation of ERK-2 increases escape-directed behavior in the rat forced swim test, thus providing insight into the neurobiological mechanisms that mediate antidepressant efficacy. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30907619      PMCID: PMC6712563          DOI: 10.1037/bne0000303

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  46 in total

1.  Social defeat stress induces a depression-like phenotype in adolescent male c57BL/6 mice.

Authors:  Sergio D Iñiguez; Lace M Riggs; Steven J Nieto; Genesis Dayrit; Norma N Zamora; Kristi L Shawhan; Bryan Cruz; Brandon L Warren
Journal:  Stress       Date:  2014-05       Impact factor: 3.493

2.  Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.

Authors:  Sergio D Iñiguez; Brandon L Warren; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

3.  A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Authors:  Catharine H Duman; Lee Schlesinger; Masafumi Kodama; David S Russell; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2006-08-30       Impact factor: 13.382

Review 4.  Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.

Authors:  John F Cryan; Rita J Valentino; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

5.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  The evolution of the MAP kinase pathways: coduplication of interacting proteins leads to new signaling cascades.

Authors:  D R Caffrey; L A O'Neill; D C Shields
Journal:  J Mol Evol       Date:  1999-11       Impact factor: 2.395

7.  Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress.

Authors:  Sergio D Iñiguez; Vincent Vialou; Brandon L Warren; Jun-Li Cao; Lyonna F Alcantara; Lindsey C Davis; Zarko Manojlovic; Rachael L Neve; Scott J Russo; Ming-Hu Han; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

8.  The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression.

Authors:  Maya First; Irit Gil-Ad; Michal Taler; Igor Tarasenko; Nurit Novak; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2011-04-09       Impact factor: 3.444

Review 9.  The molecular neurobiology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

10.  Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies.

Authors:  T G Boulton; M H Cobb
Journal:  Cell Regul       Date:  1991-05
View more
  5 in total

1.  Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.

Authors:  Jorge A Sierra-Fonseca; Minerva Rodriguez; Anapaula Themann; Omar Lira; Francisco J Flores-Ramirez; Javier Vargas-Medrano; Bharathi S Gadad; Sergio D Iñiguez
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

2.  Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood.

Authors:  Francisco J Flores-Ramirez; Anapaula Themann; Jorge A Sierra-Fonseca; Israel Garcia-Carachure; Samuel A Castillo; Minerva Rodriguez; Omar Lira; Joshua Preciado-Piña; Brandon L Warren; Alfred J Robison; Sergio D Iñiguez
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.996

3.  Exploring the Mechanism of Action of Herbal Medicine (Gan-Mai-Da-Zao Decoction) for Poststroke Depression Based on Network Pharmacology and Molecular Docking.

Authors:  Zhicong Ding; Fangfang Xu; Qidi Sun; Bin Li; Nengxing Liang; Junwei Chen; Shangzhen Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-21       Impact factor: 2.629

4.  Adolescent Fluoxetine Exposure Induces Persistent Gene Expression Changes in the Hippocampus of Adult Male C57BL/6 Mice.

Authors:  Sergio D Iñiguez; Francisco J Flores-Ramirez; Anapaula Themann; Omar Lira
Journal:  Mol Neurobiol       Date:  2020-11-25       Impact factor: 5.590

5.  Dorsal Hippocampus ERK2 Signaling Mediates Anxiolytic-Related Behavior in Male Rats.

Authors:  Jorge A Sierra-Fonseca; Lyonna F Parise; Francisco J Flores-Ramirez; Eden H Robles; Israel Garcia-Carachure; Sergio D Iñiguez
Journal:  Chronic Stress (Thousand Oaks)       Date:  2019-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.